Takehiro Suzuki

2.8k total citations
42 papers, 1.3k citations indexed

About

Takehiro Suzuki is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Takehiro Suzuki has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 10 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Takehiro Suzuki's work include Renal and Vascular Pathologies (9 papers), Dialysis and Renal Disease Management (7 papers) and MRI in cancer diagnosis (5 papers). Takehiro Suzuki is often cited by papers focused on Renal and Vascular Pathologies (9 papers), Dialysis and Renal Disease Management (7 papers) and MRI in cancer diagnosis (5 papers). Takehiro Suzuki collaborates with scholars based in Japan, United States and Mexico. Takehiro Suzuki's co-authors include Takaaki Abe, Sadayoshi Ito, Eikan Mishima, Kôichi Kikuchi, Chitose Suzuki, Yasutoshi Akiyama, Tomoyoshi Soga, Yoichi Takeuchi, Takafumi Toyohara and Yoshihisa Tomioka and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Takehiro Suzuki

40 papers receiving 1.2k citations

Peers

Takehiro Suzuki
Alberto Lázaro Spain
Eikan Mishima Japan
Jeffrey W. Meeusen United States
Xi Zheng China
Dominique Werner Switzerland
Masayuki Kato Japan
Thomas J. Velenosi Canada
Mark T. Houser United States
Michele Visentin Switzerland
Michael Spino Canada
Alberto Lázaro Spain
Takehiro Suzuki
Citations per year, relative to Takehiro Suzuki Takehiro Suzuki (= 1×) peers Alberto Lázaro

Countries citing papers authored by Takehiro Suzuki

Since Specialization
Citations

This map shows the geographic impact of Takehiro Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takehiro Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takehiro Suzuki more than expected).

Fields of papers citing papers by Takehiro Suzuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takehiro Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takehiro Suzuki. The network helps show where Takehiro Suzuki may publish in the future.

Co-authorship network of co-authors of Takehiro Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Takehiro Suzuki. A scholar is included among the top collaborators of Takehiro Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takehiro Suzuki. Takehiro Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Suzuki, Takehiro, et al.. (2023). Gestational arsenic exposure induces anxiety-like behaviors in F1 female mice by dysregulation of neurological and immunological markers. Environmental Health and Preventive Medicine. 28(0). 43–43. 10 indexed citations
3.
Obata, Yoko, Takehiro Suzuki, Chitose Suzuki, et al.. (2021). Mitochonic acid-5 ameliorates chlorhexidine gluconate-induced peritoneal fibrosis in mice. Medical Molecular Morphology. 55(1). 27–40. 6 indexed citations
4.
Mishima, Eikan, Takehiro Suzuki, Takafumi Toyohara, et al.. (2020). Concurrent analogous organ damage in the brain, eyes, and kidneys in malignant hypertension: reversible encephalopathy, serous retinal detachment, and proteinuria. Hypertension Research. 44(1). 88–97. 12 indexed citations
5.
Mishima, Eikan, Takayasu Mori, Yoko Nakajima, et al.. (2020). HPRT-related hyperuricemia with a novel p.V35M mutation in HPRT1 presenting familial juvenile gout. CEN Case Reports. 9(3). 210–214. 8 indexed citations
6.
7.
Ohnuma, Shinobu, Yoshitake Kanazawa, Keisuke Sato, et al.. (2019). The indole compound MA-35 attenuates tumorigenesis in an inflammation-induced colon cancer model. Scientific Reports. 9(1). 12739–12739. 19 indexed citations
8.
Mishima, Eikan, Takehiro Suzuki, Junichiro Hashimoto, Takaaki Abe, & Sadayoshi Ito. (2017). ‘Lead pipe’-like stiff aorta with grossly widened pulse pressure in burned-out Takayasu arteritis. European Heart Journal - Cardiovascular Imaging. 18(7). 819–819. 2 indexed citations
9.
Mishima, Eikan, Shinji Fukuda, Akinori Yuri, et al.. (2017). Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS–based metabolomics approach. Kidney International. 92(3). 634–645. 184 indexed citations
10.
Mishima, Eikan, Yasutoshi Akiyama, Kunihiko Itoh, et al.. (2015). Immuno-Northern Blotting: Detection of RNA Modifications by Using Antibodies against Modified Nucleosides. PLoS ONE. 10(11). e0143756–e0143756. 72 indexed citations
11.
Mishima, Eikan, Shinji Fukuda, Hisato Shima, et al.. (2014). Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD. Journal of the American Society of Nephrology. 26(8). 1787–1794. 152 indexed citations
12.
Takeuchi, Yoichi, Eikan Mishima, Hisato Shima, et al.. (2014). Exonic Mutations in the SLC12A3 Gene Cause Exon Skipping and Premature Termination in Gitelman Syndrome. Journal of the American Society of Nephrology. 26(2). 271–279. 36 indexed citations
13.
Akiyama, Yasutoshi, Kôichi Kikuchi, Daisuke Saigusa, et al.. (2013). Indoxyl Sulfate Down-Regulates SLCO4C1 Transporter through Up-Regulation of GATA3. PLoS ONE. 8(7). e66518–e66518. 21 indexed citations
14.
Toyohara, Takafumi, Takehiro Suzuki, Yasutoshi Akiyama, et al.. (2011). Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model. Clinical and Experimental Nephrology. 15(5). 676–687. 21 indexed citations
15.
Souma, Tomokazu, Michiaki Abe, Takashi Moriguchi, et al.. (2011). Luminal Alkalinization Attenuates Proteinuria-Induced Oxidative Damage in Proximal Tubular Cells. Journal of the American Society of Nephrology. 22(4). 635–648. 28 indexed citations
16.
Suzuki, Takehiro, Takafumi Toyohara, Yasutoshi Akiyama, et al.. (2011). Transcriptional Regulation of Organic Anion Transporting Polypeptide SLCO4C1 as a New Therapeutic Modality to Prevent Chronic Kidney Disease. Journal of Pharmaceutical Sciences. 100(9). 3696–3707. 28 indexed citations
17.
Toyohara, Takafumi, Yasutoshi Akiyama, Takehiro Suzuki, et al.. (2010). Metabolomic profiling of uremic solutes in CKD patients. Hypertension Research. 33(9). 944–952. 121 indexed citations
18.
Tanemoto, Masayuki, Yoichi Takeuchi, Eikan Mishima, et al.. (2010). Stage of chronic kidney disease is an outcome-predicting factor of angioplasty for atheromatous renal artery stenosis. Hypertension Research. 33(11). 1206–1210. 6 indexed citations
19.
Suzuki, Takehiro, Stephen M. Richards, Nathaniel S. Treister, & David A. Sullivan. (2005). Antagonistic Effects of Testosterone and 17ß–Estradiol on Gene Expression in the Lacrimal and Meibomian Glands. Investigative Ophthalmology & Visual Science. 46(13). 4427–4427. 1 indexed citations
20.
Suzuki, Takehiro, et al.. (1996). Aerosolized Human Neutrophil Elastase Induces Airway Constriction and Hyperresponsiveness With Protection by Intravenous Pretreatment With Half-Length Secretory Leukoprotease Inhibitor. American Journal of Respiratory and Critical Care Medicine. 153(4). 1405–1411. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alberto Lázaro Breakdown of academic impact, for papers by Eikan Mishima Breakdown of academic impact, for papers by Jeffrey W. Meeusen Breakdown of academic impact, for papers by Xi Zheng Breakdown of academic impact, for papers by Dominique Werner Breakdown of academic impact, for papers by Masayuki Kato Breakdown of academic impact, for papers by Thomas J. Velenosi Breakdown of academic impact, for papers by Mark T. Houser Breakdown of academic impact, for papers by Michele Visentin Breakdown of academic impact, for papers by Michael Spino
Rankless by CCL
2026